Protagonist Therapeutics, Inc. <PTGX.O>: H.C. Wainwright Raises Target Price to $170 From $167
PTGX•Related News
Mettler-Toledo CEO Patrick Kaltenbach sells 942 common shares for $1,342,350
MTD•
Aifu adopts new Chinese name translation, rebrands as “智能未来集团” effective Sept. 1, 2026
AIFU•
Cyabra signs AI platform deal with Fortune Global 500 food and beverage company
CYAB•
Western Alliance Bancorporation declares dividend of R$ 1.48 per unit
WAL•
Autozi reports 66,350,064 total shares outstanding as of Aug. 31, 2026
AZI•